The comparison study to Triiodothyronine (T3) levels in severe and non-severe covid-19 infections in Babylon province
Department of Pathology and Forensic Medicine, Hammurabi College of Medicine, University of Babylon, Babil, Iraq.
Research Article
GSC Advanced Research and Reviews, 2025, 22(02), 113-120.
Article DOI: 10.30574/gscarr.2025.22.2.0048
Publication history:
Received on 02 January 2025, revised on 08 February 2025; accepted on 11 February 2025
Abstract:
In addition to evaluating thyroid hormone levels as a possible predictor of illness severity, this reading sought to regulate the reminder among disease severity and demographic characteristics (age, gender, blood group, vaccination status, and geographic distribution) in recovered COVID-19 patients. 76 COVID-19 patients who received treatment at Babylon Province's Merjan Teaching Hospital between November and December 2021 were examined. Age was significantly correlated with severity (p≤0.0001), with non-severe cases being more common in those under 30 and severe cases being more common in those over 40. Gender differences were not statistically significant, despite the fact that males outnumbered females (p˃0.0001). Although there were variations between rural and urban cases (p≤0.0357), geographic location had no discernible effect. While ABO blood type affected severity While ABO blood type had no effect on severity, vaccination status did (p˃0.0001). Significant differences in T3 levels between severe and non-severe patients point to a possible function in predicting the severity of the disease. These results shed light on the biological and demographic variables affecting COVID-19 outcomes.
Keywords:
T3; Covid; Thyroid; Severity and Cytokine
Full text article in PDF:
Copyright information:
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
